Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T de Jong-van den Berg

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Annali Dell'Istituto Superiore Di Sanita|January 1, 1991
Drug utilization studies and drug monitoring in The NetherlandsF M Haaijer-Ruskamp, L T de Jong-van den Berg
Pharmacy World & Science : PWS|June 25, 1999
Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitalsR Fijn, L T de Jong-van den Berg, J R Brouwers
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Thalidomide once more in the spotlight]L T de Jong-van den Berg, J Rutgers, M C Cornel
Pharmacy World & Science : PWS|July 31, 1999
Antidepressant drug choice for first users in two regions in The NetherlandsA C Egberts, M Veenstra, L T de Jong-van den Berg
AIDS Care|February 15, 2001
Socio-economic aspects of extended STD screening in pregnancyM J Postma, J C Jager, L T de Jong-van den Berg
Nederlands Tijdschrift Voor Geneeskunde|January 6, 2001
[Deptropine still prescribed for 0-4 year olds]E Schirm, H J Gebben, H Tobi, et al.
Pediatrics|August 3, 2001
Psychotropic medication in children: a study from the NetherlandsE Schirm, H Tobi, J M Zito, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot studyA C van Grootheest, J K Groote, L T de Jong-van den Berg
Pharmacy World & Science : PWS|December 5, 2000
Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelinesR Fijn, J R Brouwers, J W Timmer, et al.
Teratology|July 21, 1999
Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy GroupL T De Jong van den Berg, N Feenstra, H T Sorensen, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Annali Dell'Istituto Superiore Di Sanita|January 1, 1991
Drug utilization studies and drug monitoring in The NetherlandsF M Haaijer-Ruskamp, L T de Jong-van den Berg
Pharmacy World & Science : PWS|June 25, 1999
Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitalsR Fijn, L T de Jong-van den Berg, J R Brouwers
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Thalidomide once more in the spotlight]L T de Jong-van den Berg, J Rutgers, M C Cornel
Pharmacy World & Science : PWS|July 31, 1999
Antidepressant drug choice for first users in two regions in The NetherlandsA C Egberts, M Veenstra, L T de Jong-van den Berg
AIDS Care|February 15, 2001
Socio-economic aspects of extended STD screening in pregnancyM J Postma, J C Jager, L T de Jong-van den Berg
Nederlands Tijdschrift Voor Geneeskunde|January 6, 2001
[Deptropine still prescribed for 0-4 year olds]E Schirm, H J Gebben, H Tobi, et al.
Pediatrics|August 3, 2001
Psychotropic medication in children: a study from the NetherlandsE Schirm, H Tobi, J M Zito, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot studyA C van Grootheest, J K Groote, L T de Jong-van den Berg
Pharmacy World & Science : PWS|December 5, 2000
Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelinesR Fijn, J R Brouwers, J W Timmer, et al.
Teratology|July 21, 1999
Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy GroupL T De Jong van den Berg, N Feenstra, H T Sorensen, et al.
Pageof 6